Andrew D. Sklawer
Net Worth

Last updated:

What is Andrew D. Sklawer net worth?

The estimated net worth of Mr. Andrew D. Sklawer is at least $2,755,369 as of 17 May 2021. He owns shares worth $292,869 as insider and has received compensation worth at least $2,462,500 in Brickell Biotech, Inc..

What is the salary of Andrew D. Sklawer?

Mr. Andrew D. Sklawer salary is $492,500 per year as Co-Founder, Chief Operating Officer & Sec. in Brickell Biotech, Inc..

How old is Andrew D. Sklawer?

Mr. Andrew D. Sklawer is 40 years old, born in 1985.

What stocks does Andrew D. Sklawer currently own?

As insider, Mr. Andrew D. Sklawer owns shares in one company:

Company Title Shares Price per share Total value
Brickell Biotech, Inc. (BBI) Co-Founder, Chief Operating Officer & Sec. 124,625 $2.35 $292,869

What does Brickell Biotech, Inc. do?

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

BBI logo
BBI
Brickell Biotech, Inc.
$2.35

Andrew D. Sklawer insider trading

Brickell Biotech, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 15,375 $0.8 $12,300
Option
Restricted Stock Units 20,000 N/A N/A
Option
Common Stock 20,000 N/A N/A
Purchase
Common Stock Warrants (right to buy) 13,044 $1.25 $16,305
Purchase
Common Stock 13,044 $1.25 $16,305

Brickell Biotech key executives

Brickell Biotech, Inc. executives and other stock owners filed with the SEC:

  • Attorney Robert Busard Brown (63) Chief Executive Officer & Director
  • Mr. Andrew D. Sklawer (40) Co-Founder, Chief Operating Officer & Sec.
  • Mr. Deepak Chadha (55) Chief R&D Officer
  • Mr. Reginald L. Hardy M.B.A., R.Ph. (67) Co-Founder & Chairman